NCT06151795View on ClinicalTrials.gov

A Study to Evaluate XTR006 in Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

September 27, 2023

Study Completion Date

January 10, 2024

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

XTR006

Single dose intravenous injection of XTR006. Serial whole-body PET scan will be obtain after injection, blood and urine collection after injection for the assessment of pharmacokinetics.

Trial Locations (1)

100089

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Sinotau Pharmaceutical Group

INDUSTRY

NCT06151795 - A Study to Evaluate XTR006 in Chinese Volunteers | Biotech Hunter | Biotech Hunter